Task id=task-application fullUrl=(none)Code: id=(none) fullUrl=(none)Variation Type II [(100000155693)] (https://spor.ema.europa.eu/v1/lists/100000155688)
Identifier: EMEA/H/C/XXXX/WS/1965/G (http://ema.europa.eu/fhir/procedureIdentifierNumber)
Status: requested
Intent: order
Date: Next Production Run/Next Printing - false
Task id=variation-1 fullUrl=(none)Code: C.I.4 - SAFETY, EFFICACY, PHARMACOVIGILANCE CHANGES - HUMAN AND VETERINARY MEDICINAL PRODUCTS - Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data [(C.I.4)] (https://spor.ema.europa.eu/v1/lists/100000152091-todo-scope-type)
Status: requested
Intent: order
InputType: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: II [(typeII)] (https://spor.ema.europa.eu/v1/lists/100000155688-temp)
InputType: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: II [(typeIIapplicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
InputType: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IIart29 [(typeIIart29applicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
InputType: Article 5 [(exampleArticle5Code)] (https://spor.ema.europa.eu/v1/lists/900000003554-dummy)
Value: true
Task id=variation-2 fullUrl=(none)Code: C.I.4 - SAFETY, EFFICACY, PHARMACOVIGILANCE CHANGES - HUMAN AND VETERINARY MEDICINAL PRODUCTS - Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data [(C.I.4)] (https://spor.ema.europa.eu/v1/lists/100000152091-todo-scope-type)
Status: requested
Intent: order
InputType: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: II [(typeII)] (https://spor.ema.europa.eu/v1/lists/100000155688-temp)
InputType: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: II [(typeIIapplicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
InputType: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IIart29 [(typeIIart29applicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
InputType: Article 5 [(exampleArticle5Code)] (https://spor.ema.europa.eu/v1/lists/900000003554-dummy)
Value: true
Task id=variation-3 fullUrl=(none)Code: C.z - SAFETY, EFFICACY, PHARMACOVIGILANCE CHANGES - Other variation [(C.z)] (https://spor.ema.europa.eu/v1/lists/100000152091-todo-scope-type)
Status: requested
Intent: order
InputType: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IBunforeseen [(typeIBun)] (https://spor.ema.europa.eu/v1/lists/100000155688-temp)
InputType: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IBunforeseen [(typeIBunapplicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
InputType: Article 5 [(exampleArticle5Code)] (https://spor.ema.europa.eu/v1/lists/900000003554-dummy)
Value: true
Focus:
Wonderpill (MedicinalProductDefinition[id=
variationProduct-1-1-1])
Focus:
WonderDrug (MedicinalProductDefinition[id=
variationProduct-1-1-2])
Focus:
WonderCap (MedicinalProductDefinition[id=
variationProduct-1-1-3])
InputType: Grouping details [(grouping-code-tbc)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Grouped Regulatory Activity [(100000155555)] (https://spor.ema.europa.eu/v1/lists/100000155553)
InputType: Regulatory Activity subject to a Worksharing Agreement [(100000155556)] (https://spor.ema.europa.eu/v1/lists/100000155553)
Value: true
InputType: Change concern [(change-concern)] (https://spor.ema.europa.eu/v1/lists/example/variation-parameter-tbc)
Value: id=(none) fullUrl=(none)Other [(other)] (https://spor.ema.europa.eu/v1/lists/example/change-concern-type-tbc)
InputType: Domain [(100000000777)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
InputType: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Variation Type IB unforseen (invented) [((unknown))] (https://spor.ema.europa.eu/v1/lists/100000155688)
InputType: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Variation Type II [(100000155693)] (https://spor.ema.europa.eu/v1/lists/100000155688)
InputType: Scope [(100000000999-example)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: Type of the Variation Application:1) Type II variation C.I.4: Variations related to significant modifications of the Summary of Product Characteristics intended to improve the manufacturing process and the quality of the medicinal product concerned or its active substance(s)”.
InputType: Other Applications [(100000000999-example)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: Not provided as this variation application is a worksharing procedure affecting more than one procedure.
InputType: Annexed Documents [(100000000776)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Reference: DocumentReference/doc-ref-summary, summary
InputType: Annexed Documents [(100000000776)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Reference: DocumentReference/doc-ref-labelling, labelling
InputType: Annexed Documents [(100000000776)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Reference: DocumentReference/doc-ref-package, package
InputType: noOtherChanges [(100000002345-temp-noOtherChanges)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
InputType: conditionsSet [(100000002345-temp-conditionsSet)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
InputType: submitted [(100000002345-temp-submitted)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
InputType: sharing [(100000002345-temp-sharing)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
ForSanofi Pasteur LOC-100010589 (https://spor.ema.europa.eu/v1/locations)
Requested byOrganization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
↸arrow indicates that this points back to the parent Task rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
Payment Notice id=(none) fullUrl=(none)Identifier: not applicable (https://spor.ema.europa.eu/v1/po-number)
Notice of Payment Created: 2019-09-16
Status: active
Payment status: not paid
Fee not paid reason: Invoiced
ProviderOrganization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
↸arrow indicates that this points back to the parent Task rather then being linked forwards from it
Provenance (Signature) id=signature-id fullUrl=(none)
Type: Author's Signature [(1.2.840.10065.1.12.1.1)] (urn:iso-astm:E1762-95:2013)
When: 2020-10-28
ByRole id=signature-person-id fullUrl=(none) -
id=(none) fullUrl=(none)Regulatory Product Manager [(tbc)] (https://spor.ema.europa.eu/v1/lists/100000154441)Practitioner id=signature-practitioner-id fullUrl=(none)Name: Mrs Bob Billy
Organization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Grouping - Confirm authority to sign: true
Recorded date: 2020-10-28
Activity: attest (http://terminology.hl7.org/CodeSystem/iso-21089-lifecycle)
Product id=variationProduct-1-1-1 fullUrl=(none)Name: Wonderpill
Invented name part: Wonderpill
Pharmaceutical dose form name part: Suspension for injection
Domain: Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
Administrable version of product id=(none) fullUrl=(none)Administrable Dose Form: id=(none) fullUrl=(none)Suspension for injection [(100000073864)] (https://spor.ema.europa.eu/v1/lists/200000000004)
Route of Administration: ()unknown ()
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-1-euAuthorisation fullUrl=(none)Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: See Annex A (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Status date: 2016-02-17
HolderSanofi LOC-100010589 (https://spor.ema.europa.eu/v1/locations)
Granted by: Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case Type: Centralised Procedure [(100000155059)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application Type: Variation Type II [(100000155693)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Provenance (Change) id=prov-id-1 fullUrl=(none)Recorded date: 2020-10-28
Based on: C.I.4
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-1]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-2]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-3]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Activity: UPDATE (http://terminology.hl7.org/CodeSystem/v3-DataOperation)
AgentOrganization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Product id=variationProduct-1-1-2 fullUrl=(none)Name: WonderDrug
Invented name part: WonderDrug
Pharmaceutical dose form name part: Suspension for injection
Domain: Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
Administrable version of product id=(none) fullUrl=(none)Administrable Dose Form: id=(none) fullUrl=(none)Suspension for injection [(100000073864)] (https://spor.ema.europa.eu/v1/lists/200000000004)
Route of Administration: ()unknown ()
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-2-euAuthorisation fullUrl=(none)Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: See Annex A (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Status date: 2016-02-17
HolderSanofi LOC-100010589 (https://spor.ema.europa.eu/v1/locations)
Granted by: Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case Type: Centralised Procedure [(100000155059)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application Type: Variation Type II [(100000155693)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Provenance (Change) id=prov-id-1 fullUrl=(none)Recorded date: 2020-10-28
Based on: C.I.4
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-1]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-2]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-3]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Activity: UPDATE (http://terminology.hl7.org/CodeSystem/v3-DataOperation)
AgentOrganization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Product id=variationProduct-1-1-3 fullUrl=(none)Name: WonderCap
Invented name part: WonderCap
Pharmaceutical dose form name part: Suspension for injection
Domain: Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
(unknown resource type)
which is linked to this by contained resource.id
Administrable version of product id=(none) fullUrl=(none)Administrable Dose Form: id=(none) fullUrl=(none)Suspension for injection [(100000073864)] (https://spor.ema.europa.eu/v1/lists/200000000004)
Route of Administration: ()unknown ()
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-3-euAuthorisation fullUrl=(none)Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: See Annex A (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Status date: 2016-02-17
HolderSanofi LOC-100010589 (https://spor.ema.europa.eu/v1/locations)
Granted by: Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case Type: Centralised Procedure [(100000155059)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application Type: Variation Type II [(100000155693)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Provenance (Change) id=prov-id-1 fullUrl=(none)Recorded date: 2020-10-28
Based on: C.I.4
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-1]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-2]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=
variationProduct-1-1-3]
Old data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
New data: "Please refer to the comparative table for detailed comparison between the present and proposed information."
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Activity: UPDATE (http://terminology.hl7.org/CodeSystem/v3-DataOperation)
AgentOrganization id=applicant-org-id fullUrl=(none)Identifier: ORG-100000788 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Sanofi Pasteur
email: billy.bob@company.com
Phone: +33 (0)4 1233455
Address:
Campus Merieux
1541 Avenue Marcel Merieux
Marcy L'Etoile
69280
France (France [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)Identifier: LOC-100001840 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Warning - Found 3 copies of Ingredient DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)(id=Ingredient-p1-1)(id=Ingredient-p2-1)(id=Ingredient-p3-1).
Warning - Found 3 copies of Ingredient DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)(id=Ingredient-p1-1)(id=Ingredient-p2-1)(id=Ingredient-p3-1).
Warning - Found 3 copies of Ingredient DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)(id=Ingredient-p1-1)(id=Ingredient-p2-1)(id=Ingredient-p3-1).
Warning - Found 3 copies of RegulatedAuthorization See Annex A(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-2-euAuthorisation)(id=ra-red-1-blue-1-3-euAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization See Annex A(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-2-euAuthorisation)(id=ra-red-1-blue-1-3-euAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization See Annex A(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-2-euAuthorisation)(id=ra-red-1-blue-1-3-euAuthorisation).